Lunchtime Live

HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients

13 min · I går
Forsidebilde av episoden HSE approves offer on Skyclarys drug for Friedreich's Ataxia patients

Beskrivelse

The HSE today has approved a new offer from drug firm Biogen over ‘Skyclarys’, which will now be available with reimbursement to Friedreich’s Ataxia patients. This comes after mounting pressure, and months of campaigning… Joining Clare McKenna to discuss this is Teresa Kane, a mother of two children with Friedreich’s Ataxia and Niamh Ní Hoireabhaird, who lives with Friedrich’s Ataxia…

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Lunchtime Live sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / måned etter prøveperioden. · Avslutt når som helst

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

298 Episoder